|By PR Newswire||
|April 1, 2014 08:00 PM EDT||
DUBLIN, April 2, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/pttfr4/cancer_gene) has announced the addition of the "Cancer Gene Therapy Market Analysis" report to their offering.
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer.
The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant share of more than 60% in the overall number of clinical studies. The reasons for cancer to become a preferred area of application for gene therapy are the significant unmet medical needs in cancer therapy, coupled with the large size of its market. Additionally, the ethical acceptance of gene therapy as a therapeutic solution also contributed to the shift of focus from monogenetic diseases to cancer.
A major part of the cancer gene therapy products for are currently in preclinical and Phase II of clinical trials. There has been marginal success in developing completely curative therapeutic drugs. The gene therapy drugs which have been approved till date are Gendicine & Rexin-G. Gendicine, which is developed by Shenzhen SiBiono Gene Technologies Co., is currently marketed only in China and Rexin-G in Philippines.
Gene therapy offers a large window of opportunities for the treatment of multiple cancers. The therapy has been found to be able to deliver special tumor suppressor genes to an individual, which could prevent the growth of malignant tumors and also reduce the metastatic disease. . The major concentration is being given to the rare tumor types such as pancreatic cancer, and highly prevalent tumor types such as breast cancer and prostate cancer. With the prevalence of cancer rising significantly, the future drug pipelines of the companies are mostly focusing on gene therapy for cancer.
Key Topics Covered:
1. Introduction to Gene Therapy
2. Global Gene Therapy Market
3. Significance of Cancer Therapeutics in Gene Therapy
4. Current Applications of Gene Therapy to Cancer Treatment
5. Cancer Gene Therapy Market Dynamics
6. Regulatory Scenario for Gene Therapy Market
7. Cancer Gene Therapy Drug Clinical Trial Insight by Phase, Country & Target Indications
8. Marketed Cancer Gene Therapy Drugs
9. Suspended & Discontinued Cancer Gene Therapy Drug Pipeline
10. Competitive Landscape
- Cell Genesys
- Epeius Biotechnologies
- Introgen Therapeutics
- Shenzhen SiBiono GeneTech
- ZIOPHARM Oncology
For more information visit http://www.researchandmarkets.com/research/pttfr4/cancer_gene
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Sep. 29, 2016 07:15 AM EDT Reads: 1,726
Sep. 29, 2016 07:00 AM EDT Reads: 3,483
Sep. 29, 2016 07:00 AM EDT Reads: 3,410
Sep. 29, 2016 07:00 AM EDT Reads: 2,272
Sep. 29, 2016 07:00 AM EDT Reads: 2,935
Sep. 29, 2016 06:45 AM EDT Reads: 3,179
Sep. 29, 2016 06:45 AM EDT Reads: 1,671
Sep. 29, 2016 06:15 AM EDT Reads: 1,471
Sep. 29, 2016 06:00 AM EDT Reads: 2,679
Sep. 29, 2016 06:00 AM EDT Reads: 524
Sep. 29, 2016 06:00 AM EDT Reads: 2,760
SYS-CON Events announced today that Roundee / LinearHub will exhibit at the WebRTC Summit at @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. LinearHub provides Roundee Service, a smart platform for enterprise video conferencing with enhanced features such as automatic recording and transcription service. Slack users can integrate Roundee to their team via Slack’s App Directory, and '/roundee' command lets your video conference ...
Sep. 29, 2016 05:45 AM EDT Reads: 1,502
Sep. 29, 2016 05:45 AM EDT Reads: 1,052
Apache Hadoop is a key technology for gaining business insights from your Big Data, but the penetration into enterprises is shockingly low. In fact, Apache Hadoop and Big Data proponents recognize that this technology has not yet achieved its game-changing business potential. In his session at 19th Cloud Expo, John Mertic, director of program management for ODPi at The Linux Foundation, will explain why this is, how we can work together as an open data community to increase adoption, and the i...
Sep. 29, 2016 05:30 AM EDT Reads: 1,148
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Sep. 29, 2016 05:30 AM EDT Reads: 2,961